LENZ Therapeutics LENZ
NASDAQ LENZ
$3.20 -0.02 (-0.47%)
As of: Oct 22, 2026 · 11:56 AM EDT

LENZ Therapeutics (LENZ) Share-based Compensation (2020 - 2026)

Updated

LENZ Therapeutics' Share-based Compensation came in at $4.47 million for Q2 2026, up 57.2% from $2.85 million a year earlier and up 3.5% from the prior quarter.

Analysis

LENZ Therapeutics (LENZ) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, LENZ Therapeutics reported Share-based Compensation of $15.94 million, up 72.8% year-over-year; for FY2025, it came in at $12.55 million, up 97.1% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 134.5% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $6.37 million in FY2024 (+373.9%), $1.34 million in FY2023 (-90.1%), $13.53 million in FY2022 (+71.9%) and $7.87 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q3 2020.
  • Year-over-year, Share-based Compensation has increased for ten consecutive quarters, with growth averaging 139.5% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q2 2024 (growth of 745.0%), and the weakest in Q1 2023 (a decline of 95.8%).
  • Business Quant data shows LENZ's Share-based Compensation at $4.32 million (Q1 2026), $3.68 million (Q4 2025) and $3.47 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,170.86 Bn 1,139.45 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 458.00 Mn
3 AbbVie 501.68 Bn 474.79 Bn 12.70 Bn 166.00 Mn
4 Merck 374.79 Bn 329.16 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 302.69 Bn 266.68 Bn 11.24 Bn -
6 Astrazeneca 268.27 Bn 241.96 Bn 12.86 Bn -
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 193.38 Bn 167.58 Bn 6.22 Bn 231.00 Mn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn 249.00 Mn
10 LENZ Therapeutics 100.55 Mn -872.35 Mn 5.21 Mn 4.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.47 Mn
Mar 31, 2026 4.32 Mn
Dec 31, 2025 3.68 Mn
Sep 30, 2025 3.47 Mn
Jun 30, 2025 2.85 Mn
Mar 31, 2025 2.56 Mn
Dec 31, 2024 1.63 Mn
Sep 30, 2024 2.19 Mn
Jun 30, 2024 1.60 Mn
Mar 31, 2024 947,000.00
Dec 31, 2023 518,000.00
Sep 30, 2023 2.16 Mn
Jun 30, 2023 2.85 Mn
Mar 31, 2023 142,000.00
Dec 31, 2022 3.62 Mn
Sep 30, 2022 3.21 Mn
Jun 30, 2022 3.36 Mn
Mar 31, 2022 3.34 Mn
Dec 31, 2021 2.45 Mn
Sep 30, 2021 2.37 Mn
API Access

LENZ Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=LENZ&period=max&api_key=YOUR_API_KEY